Categories Earnings, Health Care
Earnings Summary: Bio-Techne Corp (TECH) reports higher Q4 profit, revenue
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase in profit.
- Fourth-quarter revenue increased by 5% to $301.3 million; organic sales grew by 5%
- Earnings per share, on a reported basis, was $0.47 in the June quarter, vs. $0.38 in the year-ago period
- Adjusted earnings increased to $0.55 per share in Q4 from $0.51 per share a year earlier
- Q4 operating income increased 17% YoY to $94.5 million from $80.6 million in the fourth quarter of fiscal 2022
- Operating margin was 31.4%, on a reported basis, compared to 28.0% a year earlier
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
